Smith & Nephew CEO Olivier Bohuon reportedly tells employees that he's not in the running for the top job at French drug maker Sanofi.
Smith & Nephew CEO Olivier Bohuon is said to be a leading candidate for the top job at French drugmaker Sanofi, which axed its CEO last week without a replacement.
Medtronic and Sanofi embark on a global alliance to combine human and financial resources in the interest of new products and services for patients with diabetes.
Sanofi subsidiary Genzyme agrees to pay $22.3 million to settle accusations that its sales rep encouraged off-label use of the Seprafilm surgical product.
Massachusetts-based Genzyme Corp., a subsidiary of Sanofi (NYSE:SNY), agreed to pay $22.3 million to settle a whistleblower lawsuit accusing the company of off-label marketing of its Seprafilm surgical product.
A pair of brokers plead guilty to charges of insider trading in Stryker Corp. stock ahead of its 2011 acquisition of Orthovita.
A pair of brokers pleaded guilty to federal insider trading charges yesterday, admitting that they used tips from a former Stryker (NYSE:SYK) marketing executive to make illicit trades ahead of the medical device company's 2011 acquisition of Orthovita.
Unilife shares are up more than 24% this week on news of a deal with MedImmune, the biologics arm of pharmaceuticals giant AstraZeneca.
Unilife (NSDQ:UNIS) shares are up more than 24% this week on a supply deal for its wearable injectors it inked with MedImmune, the biologics division of pharma giant AstraZeneca (NYSE:AZN).
Unilife CEO Alan Shortall says a pair of Forbes articles were "vindictive," "malicious" and a "slap in the face" to analysts and portfolio managers who put their trust in the company.